Comparison of the Effects of Sugammadex and Neostigmine on Early Extubation, Intensive Care Unit Admission and Length of Stay, and Hospital Costs in Adult Cranial Surgery
NCT ID: NCT06987357
Last Updated: 2025-05-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
112 participants
OBSERVATIONAL
2021-05-01
2021-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sugammadex Versus Neostigmine Use in Patients Undergoing Septoplasty Operations
NCT02026999
Blood Sugar Level and Postoperative Agitations in Pediatric Surgery
NCT04193280
Comparison of the Performances of the cTOFR and the mTOFR During Reversal of Deep Neuromuscular Blockade With Sugammadex
NCT06220136
Sugammadex Dosing: Anaesthesiologist Clinical Perception Versus Quantitative Monitoring
NCT04762420
Evaluation of Oxygen Reserve Index According to Glasgow Coma Scale in Providing Oxygenation in Intracranial Surgery
NCT05953493
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group Neostigmine
No interventions assigned to this group
Group Sugammadex
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* over the age of 18,
* who underwent elective surgery,
* underwent general anesthesia with sevoflurane anesthesia from volatile anesthetics,
* used rocuronium as a neuromuscular blocking agent
Exclusion Criteria
* ASA IV and above,
* who underwent surgery under emergency conditions,
* who have incomplete follow-up form records and electronic media data,
* who were taken to the intensive care unit without neuromuscular blockade antagonism due to long surgery,
* who were treated with a neuromuscular blocking agent other than rocuronium,
* who were treated with a volatile anesthetic other than sevoflurane or with total intravenous anesthesia.
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kanuni Sultan Suleyman Training and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Naime Yalçın
Specialist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kanuni Sultan Suleyman Training and Research Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KAEK/2021.04.116
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.